🔍 Check out the latest on treating inborn errors of immunity with our VP of Clinical Services, Dr. Heather Stefanski. Discover how new gene therapies are changing lives and shaping the future of #immunodeficiency care. bit.ly/3TRczAs

Curious about how #artificialintelligence is revolutionizing the #celltherapy field? Join our very own Abeer Madbouly, PhD and an expert panel next week for a discussion on #AI's game-changing role in donor availability. Save your spot 👉 bit.ly/3ShU6L0

Don't miss this week's webinar on #AI's role in #celltherapy! 🔍 Learn how to predict stem cell donor availability and enhance your donor pool selection. Save your spot for these valuable insights 👉 bit.ly/3ShU6L0

📰 Exciting news! We're thrilled to welcome Tom Hochuli our new president of NMDP BioTherapies! His 30 years of expertise in regulated industries, including #cellandgenetherapy, is set to drive our innovation forward. Get the scoop on Tom's role 👉 bit.ly/48RgHVK

Wondering how to tackle the complexities of allogeneic #celltherapy #clinicaltrials? Our clinical operations expert Kathleen Kane breaks down key strategies: protocol design, leveraging CRO expertise and specialized partnerships. Check out her insights 👉 bit.ly/3OANshI

Joining us at #Tandem24? Don't miss: ➡️ Action on health disparities at the @ASTCT/NMDP ACCESS Initiative Workshop ➡️ Expert insights on #GVHD prevention & donor strategies ➡️ Milestone celebrations and a moving donor/recipient meeting Full agenda 👉 bit.ly/3SyPZKF

Recruiting skilled clinical research staff is a challenge. Watch a preview of the #ACRP2024 session where NMDP BioTherapies leaders share how their organization addressed this by creating a CRA training program to prepare new hires. Find out more > bit.ly/48hHIQT

If you're wondering how race, ethnicity and ancestry impact #HLA genotyping, check out our bioinformatics expert Abeer Madbouly's latest convo with ASHI HLA about how these factors impact #celltherapy science 👉 bit.ly/3SNPpse

Who else is heading to San Antonio for #Tandem24 this week? Make sure to stop by and meet our new president, Tom Hochuli, and find out how we're supporting organizations in their next-generation therapy development. Let's shape the future of #cellandgenetherapy together!

A special thank you to our Scientific Organizing Committee and program chairs as we kick off #Tandem24 this morning!! ASTCT

San Antonio is buzzing at #Tandem24! Join us at booth #528 and let's chat about how we're working together to break down barriers to #celltherapy and leading groundbreaking research. See you soon! 👋

Tonight at #Tandem24 🌟 Join our NMDP Reception to mark the Amy Scholar Program's 25th anniversary and the inaugural Buchbinder Award. Plus, witness the heartwarming meeting between transplant recipient Johanna and her donor Cat. An evening of milestones and emotions awaits!

Happy #InternationalWomensDay! 🌟 Join us in showing appreciation to the incredible women leading #celltherapy innovation and shaping the future of care! Together, they #InspireInclusion to drive access to life-saving therapies for all patients in need.

San Diego, here we come! The #InnateKillerSummit is THE place for the latest in #NKcell therapies. 🧬 Will we see you there next week? Let’s push the future of patient care forward. Check out the full agenda 👉 innate-killer.com

Attending the #InnateKillerSummit? Join our VP of Research Martin Maiers at 3:00 p.m. this afternoon for a deep dive on #NKcell signals & the latest in genomic insights. You won't want to miss these insights. Check out the full summit agenda for details 👉 innate-killer.com

Exciting update for #celltherapy developers! 🌟 We've enhanced our cellular starting material offerings, adding a Drug Master File to our GMP leukopak, streamlining regulatory filings and offering faster, more customizable solutions. Find out more 👉 bit.ly/3xMAlUX

Don't miss tomorrow's deep dive on sourcing high-quality starting material, navigating international regulations and effectively using standardized leukopaks for allogeneic therapies. Save your spot for an insightful discussion 👉 bit.ly/3Q2bTVY

🌟 Exciting news! Our CIBMTR CRO Services now offers rapid site activation for quicker #clinicaltrial enrollment in cell and gene therapies. Find out more about how we're fast-tracking trials at #ACRP2024 May 3-7 👉 bwnews.pr/3whLDAk